Raphaël Bejuit

1.2k total citations
10 papers, 525 citations indexed

About

Raphaël Bejuit is a scholar working on Genetics, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Raphaël Bejuit has authored 10 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Pathology and Forensic Medicine and 3 papers in Neurology. Recurrent topics in Raphaël Bejuit's work include Neurogenetic and Muscular Disorders Research (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Autoimmune Bullous Skin Diseases (2 papers). Raphaël Bejuit is often cited by papers focused on Neurogenetic and Muscular Disorders Research (3 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Autoimmune Bullous Skin Diseases (2 papers). Raphaël Bejuit collaborates with scholars based in France, United Kingdom and United States. Raphaël Bejuit's co-authors include Philippe Truffinet, Vincent Meininger, Gilbert Bensimon, Lucette Lacomblez, Jean-Christophe Delumeau, Christina Soubrane, Peter K. Wung, Luca Richeldi, P. Nigel Leigh and Bruno Crestani and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

Raphaël Bejuit

10 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphaël Bejuit France	7	173	121	115	114	81	10	525
Megumi Yamada Japan	14	355 2.1×	115 1.0×	69 0.6×	47 0.4×	154 1.9×	49	802
Junko Ikeda Japan	12	107 0.6×	75 0.6×	23 0.2×	21 0.2×	89 1.1×	57	547
Jean Claude Desport France	8	390 2.3×	315 2.6×	279 2.4×	17 0.1×	89 1.1×	13	865
Filomena Napolitano Italy	16	109 0.6×	79 0.7×	44 0.4×	55 0.5×	166 2.0×	46	626
Claus Vinter Bødker Hviid Denmark	12	195 1.1×	59 0.5×	32 0.3×	50 0.4×	110 1.4×	40	469
Shijie Liu China	14	157 0.9×	51 0.4×	36 0.3×	52 0.5×	166 2.0×	26	479
Said Dahbour Jordan	8	92 0.5×	68 0.6×	84 0.7×	32 0.3×	58 0.7×	20	342
Jinxiu Chen China	13	66 0.4×	61 0.5×	81 0.7×	19 0.2×	106 1.3×	34	515
Zhou Xiao China	13	20 0.1×	52 0.4×	60 0.5×	30 0.3×	236 2.9×	65	560

Countries citing papers authored by Raphaël Bejuit

Since Specialization

Citations

This map shows the geographic impact of Raphaël Bejuit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Bejuit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Bejuit more than expected).

Fields of papers citing papers by Raphaël Bejuit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Bejuit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Bejuit. The network helps show where Raphaël Bejuit may publish in the future.

Co-authorship network of co-authors of Raphaël Bejuit

This figure shows the co-authorship network connecting the top 25 collaborators of Raphaël Bejuit. A scholar is included among the top collaborators of Raphaël Bejuit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphaël Bejuit. Raphaël Bejuit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Vermersch, Patrick, Cristina Granziera, Yang Mao‐Draayer, et al.. (2024). Inhibition of CD40L with Frexalimab in Multiple Sclerosis. New England Journal of Medicine. 390(7). 589–600. 34 indexed citations

Giovannoni, Gavin, Cristina Granziera, Yang Mao‐Draayer, et al.. (2024). 151. Safety and Efficacy of Frexalimab in the Treatment of Relapsing Multiple Sclerosis: 18-month Results from the Phase 2 Open-Label Extension. Multiple Sclerosis and Related Disorders. 92. 106112–106112. 1 indexed citations

Allanore, Yannick, Peter K. Wung, Christina Soubrane, et al.. (2020). A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis. Annals of the Rheumatic Diseases. 79(12). 1600–1607. 72 indexed citations

Allanore, Yannick, Peter K. Wung, Christina Soubrane, et al.. (2020). OP0250 EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY. Annals of the Rheumatic Diseases. 79. 157–158. 6 indexed citations

Raghu, Ganesh, Luca Richeldi, Bruno Crestani, et al.. (2018). SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772). European Respiratory Journal. 52(6). 1801130–1801130. 70 indexed citations

Landi, Francesco, Matteo Cesari, Riccardo Calvani, et al.. (2017). The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: design and methods. Aging Clinical and Experimental Research. 29(1). 89–100. 123 indexed citations

Lacomblez, Lucette, Gilbert Bensimon, P. Nigel Leigh, et al.. (2002). Long-term safety of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 3(1). 23–29. 60 indexed citations

Bensimon, Gilbert, Lucette Lacomblez, Jean-Christophe Delumeau, et al.. (2002). A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. Journal of Neurology. 249(5). 609–615. 128 indexed citations

Kennel, Philippe, Frédéric Revah, Georg Andrees Böhme, et al.. (2000). Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn). Journal of the Neurological Sciences. 180(1-2). 55–61. 28 indexed citations

10.

Bastien, Olivier, et al.. (1990). [Arrhythmia in patients with low cardiac output after valvular surgery. Randomized, double-blind comparative study of dobutamine versus enoximone].. PubMed. 83 Spec No 3. 63–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact